Medical Informatics Corp. has launched the Sickbay Experience Demo Center at Texas Medical Center's Helix Park, showcasing its FDA-cleared Sickbay platform. This interactive center demonstrates how real-time patient data from various medical devices can be integrated into a single platform to improve clinical decision-making and reduce clinician burnout. The center also fosters collaboration among health systems, device makers, and technology partners to advance virtual care and AI in healthcare. Positioned within the TMC innovation ecosystem, it aims to accelerate adoption of interoperable healthcare solutions and digital transformation in patient care.
Medical Informatics Corp.'s launch of the Sickbay Experience Demo Center is presented here with a snapshot of the health sector on Pluang as of Oct 21, 2026 03:11 WIB. Among 150 priced US health stocks, 124 rose and 26 fell today. Erasca Inc. led gains with a 7.27% rise to USD 14.61 and a full 100% buy order activity, contrasting with Liquidia Corporation's 7.03% rise to USD 36.53 but predominantly sell orders at 81%. Moderna, Inc. also rose 6.86% to USD 242.45 with a more balanced buy-sell split and a notably longer typical hold time of 59 days on Pluang.
Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...
Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
